HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hematopoietic stem cell transplantation in a patient with type 1 mosaic variegated aneuploidy syndrome.

AbstractBACKGROUND:
Mosaic variegated aneuploidy (MVA) syndrome is a chromosomal instability disorder that leads to aneuploidies of different chromosomes in various tissues. Type 1 MVA (MVA1) is caused by mutations in the budding uninhibited by benzimidazoles 1 homolog beta (BUB1B) gene. The main clinical features of MVA1 syndrome are growth and mental retardation, central nervous system anomalies, microcephaly, and predisposition to cancers. There have been no reports of hematopoietic stem cell transplantation (HSCT) in MVA patients.
RESULTS:
We report an 11-year old boy diagnosed with MVA1 syndrome. The BUB1B gene mutations c.498_505delAAACTTTA and c.1288 + 5G > A were detected using the next generation sequencing (NGS) method. The patient presented with cytopenia soon after birth, but remained stable until 9 years of age, when he developed myelodysplastic syndrome associated with monosomy of chromosome 7. Due to severe dependence on blood transfusions, a TCRαβ+/CD19+ depleted HSCT was performed from a matched unrelated donor (MUD) using a treosulfan-based reduced intensity conditioning (RIC) regimen. The engraftment occurred, and no severe toxicity was observed soon after the HSCT, but on day + 47, graft rejection was detected. It was followed by prolonged pancytopenia and sepsis with multi-organ Enterococcus faecium infection, which led to the patient's death on day + 156 after HSCT.
CONCLUSIONS:
In conclusion, we demonstrate that RIC HSCT with TCRαβ+/CD19+ depletion was well tolerated and resulted in complete hematologic recovery in our MVA1 patient, but, unfortunately, it was followed by rapid graft rejection. This fact needs to be taken into consideration for HSCT in other MVA patients.
AuthorsAlexandra Laberko, Dmitry Balashov, Elena Deripapa, Olga Soldatkina, Elena Raikina, Alexei Maschan, Galina Novichkova, Anna Shcherbina
JournalOrphanet journal of rare diseases (Orphanet J Rare Dis) Vol. 14 Issue 1 Pg. 97 (05 03 2019) ISSN: 1750-1172 [Electronic] England
PMID31053147 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, CD19
  • BUB1B protein, human
  • Cell Cycle Proteins
  • Receptors, Antigen, T-Cell, alpha-beta
  • Protein Serine-Threonine Kinases
Topics
  • Antigens, CD19 (metabolism)
  • Cell Cycle Proteins (genetics, metabolism)
  • Chromosomal Instability (genetics, physiology)
  • Chromosome Disorders (genetics, metabolism, therapy)
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Mosaicism
  • Mutation (genetics)
  • Protein Serine-Threonine Kinases (genetics, metabolism)
  • Receptors, Antigen, T-Cell, alpha-beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: